Scienture Holdings, Inc.

SCNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $8.2M — $6.7M — $15.4K — $308.1K —
Accounts Receivable $385.3K $722.5K $731.3K $590.1K — $3.7K $11.1K $10.4K
Inventory $203.1K $210.9K $213.4K $234.5K — — — $7.9K
Total Current Assets $9.2M $4.8M $7.9M $1.4M $856.6K $7.8M $6.3M $7.3M
Property, Plant & Equipment $14.5K $15.0K $15.5K $16.0K $16.5K $17.0K $17.5K $17.5K
Goodwill — — — $21.4M $21.4M $21.4M $21.4M $7.8M
Intangible Assets (Excl. Goodwill) $70.1M $70.5M $71.0M $76.4M $76.4M $76.4M $76.4M $76.4M
Total Assets $87.7M $80.7M $84.2M $104.8M $84.2M $84.2M $104.9M $94.3M
Liabilities
Accounts Payable $916.8K $1.4M $1.4M $3.7M $3.1M $3.2M $2.9M $2.9M
Total Current Liabilities $3.0M $2.8M $2.7M $7.4M $7.7M $7.5M $7.9M $5.4M
Long-Term Debt — — — $2.0M $3.6M $3.1M $2.9M —
Total Liabilities $23.6M $13.8M $14.1M $22.2M $26.4M $25.2M $25.8M $9.1M
Stockholders' Equity
Retained Earnings $-86.8M $-84.0M $-80.6M $-52.4M $-48.8M $-42.1M $-39.0M $-31.9M
Total Stockholders' Equity $64.1M $66.8M $70.1M $82.7M $77.9M $81.2M $79.1M $85.1M
← Newer Page 1 of 7 Older →